Catalog Number D134805 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problems
Cardiac Tamponade (2226); Ischemic Heart Disease (2493)
|
Event Date 12/14/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
|
Event Description
|
It was reported that a patient underwent a premature ventricular complex (pvc) ablation and during ablation, the patient experienced st elevation and pericardial effusion that required pericardiocentesis and prolonged hospitalization.During the pvc case, they had an st elevation, and after coming off ablation, they were using an ice soundstar catheter, and they found a pericardial effusion.Pericardiocentesis was performed and 205 ccs of fluid was drained.The patient stabilized.The physician thinks that the injury was caused either by the patient feeling the ablation and moving or the physician was ablating in a crevice which may have caused the injury.Patient improved but required extended hospitalization with a drain in place.No steam pop noted.No errors were observed on biosense webster equipment during the procedure.
|
|
Manufacturer Narrative
|
It was reported that a patient underwent a premature ventricular complex (pvc) ablation and during ablation, the patient experienced st elevation and pericardial effusion that required pericardiocentesis and prolonged hospitalization.During the pvc case, they had an st elevation, and after coming off ablation, they were using an ice soundstar catheter, and they found a pericardial effusion.Pericardiocentesis was performed and 205 ccs of fluid was drained.The patient stabilized.The physician thinks that the injury was caused either by the patient feeling the ablation and moving or the physician was ablating in a crevice which may have caused the injury.Patient improved but required extended hospitalization with a drain in place.No steam pop noted.No errors were observed on biosense webster equipment during the procedure.Device evaluation details: the product was returned to biosense webster (bwi) for evaluation.A visual inspection and revision of all features were performed following bwi procedures.Visual analysis revealed blood residues in the dome area and inside the irrigation holes.This issue may be related to the procedure; however, this could not be conclusively determined.The device features were reviewed, and no issues were observed during the product investigation.A manufacturing record evaluation was performed for the finished device 31165640l, and no internal action related to the complaint was found during the review.Additionally, the manufactured and expiration dates have been provided.Therefore, fields d4.Expiration date and h4.Device manufacture date have been populated.No malfunction was observed during the product analysis.The root cause of the adverse event remains unknown.In addition, no device malfunction was reported.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The instruction for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.Flush the catheter with heparinized saline prior to insertion into the body.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|